Oscar Health, Inc. (OSCR)

Oscar Health Stock Forecast

Stock Price Forecast

The 8 analysts that cover Oscar Health stock have a consensus rating of "Hold" and an average price target of $16.88, which forecasts a 0.42% increase in the stock price over the next year. The lowest target is $11 and the highest is $25.

Price Target: $16.88 (+0.42%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$11	$16.88	$17	$25
Change	-34.56%	+0.42%	+1.13%	+48.72%

Analyst Ratings

The average analyst rating for Oscar Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	0	0	0	0	0	0
Buy	1	1	1	1	1	1
Hold	2	3	5	5	5	6
Sell	3	2	1	1	1	1
Strong Sell	1	1	0	0	0	0
Total	7	7	7	7	7	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Windley Jefferies	Jefferies	Sell → Hold Upgrades $10 → $16	Sell → Hold	Upgrades	$10 → $16	-4.82%	Apr 20, 2026
Jonathan Yong UBS	UBS	Strong Sell → Hold Upgrades $12 → $17	Strong Sell → Hold	Upgrades	$12 → $17	+1.13%	Jan 9, 2026
Andrew Mok Barclays	Barclays	Sell → Hold Upgrades $13 → $18	Sell → Hold	Upgrades	$13 → $18	+7.08%	Jan 5, 2026
Dean Sublett Stephens & Co.	Stephens & Co.	Hold Initiates $17	Hold	Initiates	$17	+1.13%	Dec 11, 2025
Jessica Tassan Piper Sandler	Piper Sandler	Hold → Buy Upgrades $13 → $25	Hold → Buy	Upgrades	$13 → $25	+48.72%	Nov 26, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

19.18B

Increased by 63.89%

from 11.70B

Revenue Next Year

20.19B

Increased by 5.30%

from 19.18B

EPS This Year

0.57

from -1.69

EPS Next Year

1.22

Increased by 112.86%

from 0.57

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.89B	3.96B	5.86B	9.18B	11.70B	19.18B	20.19B
Revenue Growth	384.43%	109.27%	47.92%	56.54%	27.50%	63.89%	5.30%
EPS	-3.20	-2.85	-1.22	0.10	-1.69	0.57	1.22
EPS Growth	-	-	-	-	-	-	112.86%
Forward PE	-	-	-	-	-	29.43	13.83
No. Analysts	-	-	-	-	-	13	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028
High	19.9B	23.4B
Avg	19.2B	20.2B
Low	17.9B	15.2B

Revenue Growth

Revenue Growth	2026	2027	2028
High	70.3%	21.8%
Avg	63.9%	5.3%
Low	53.1%	-20.8%

EPS Forecast

EPS	2026	2027	2028
High	1.21	1.86
Avg	0.57	1.22
Low	-0.62	-0.10

EPS Growth

EPS Growth	2026	2027	2028
High	-	225.4%
Avg	-	112.9%
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.